Hotaling Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$2.64M Buy
23,792
+75
+0.3% +$7.67K 1.19% 26
2022
Q3
$2.04M Sell
23,717
-16,633
-41% -$1.48M 0.98% 32
2022
Q2
$3.68M Buy
40,350
+16,340
+68% +$1.45M 1.6% 13
2022
Q1
$1.97M Sell
24,010
-16,300
-40% -$1.29M 0.76% 46
2021
Q4
$3.09M Buy
40,310
+26,300
+188% +$2.09M 1.07% 29
2021
Q3
$1.05M Sell
14,010
-6,300
-31% -$479K 0.44% 67
2021
Q2
$1.58M Buy
20,310
+5,371
+36% +$399K 0.64% 59
2021
Q1
$1.1M Buy
14,939
+214
+1% +$15.8K 0.49% 63
2020
Q4
$1.15M Sell
14,725
-27
-0.2% -$2.06K 0.54% 60
2020
Q3
$1.17M Buy
14,752
+5,502
+59% +$431K 0.63% 54
2020
Q2
$683K Hold
9,250
0.39% 71
2020
Q1
$679K Hold
9,250
0.51% 61
2019
Q4
$803K Hold
9,250
0.46% 69
2019
Q3
$743K Sell
9,250
-339
-4% -$27.2K 0.48% 69
2019
Q2
$767K Sell
9,589
-150
-2% -$11.5K 0.49% 71
2019
Q1
$773K Sell
9,739
-997
-9% -$74.6K 0.52% 66
2018
Q4
$783K Buy
+10,736
New +$758K 0.64% 60

Other funds holding MRK

Hotaling Investment Management's MRK Position: Q4 2022 in Review

Hotaling Investment Management increased its Merck (MRK) stake by 0.32% in Q4 2022, buying an estimated $7.67K and bringing the position to 23,792 shares worth $2.64M. The position accounts for 1.19% of the portfolio, ranked #26.

Hotaling Investment Management first reported a position in MRK in Q4 2018 and has held it in 17 quarters since. The position peaked at $3.68M in Q2 2022. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • Hotaling Investment Management held 23,792 shares of Merck worth $2.64M as of Q4 2022.
  • Hotaling Investment Management bought 75 Merck shares in Q4 2022, an estimated $7.67K.
  • Merck made up 1.19% of Hotaling Investment Management's portfolio in Q4 2022, its #26 holding.
  • Hotaling Investment Management first reported a position in Merck in Q4 2018 and has held it in 17 quarters since.
  • Hotaling Investment Management's Merck position peaked at $3.68M in Q2 2022.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on Hotaling Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.